Switch to
More onapp

Alembic Pharmaceuticals Ltd

APLLTD
Health CarePharmaceuticals
SmallcapWith a market cap of ₹10,519 cr, stock is ranked 332
Low RiskStock is 1.41x as volatile as Nifty
535.150.00 (+0.00%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹10,519 cr, stock is ranked 332
Low RiskStock is 1.41x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
20.41
PB RatioPB Ratio
2.03
Dividend YieldDiv. Yield
1.85%
Sector PESector PE
33.51
Sector PBSector PB
4.10
Sector Div YldSctr Div Yld
0.94%

Forecast & RatingsDetailed Forecast 

33%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Alembic Pharmaceuticals Limited is a pharmaceutical company engaged in developing formulations and active pharmaceutical ingredients (API).

Financial TrendFinancial statements 

20192020202120223.944.615.485.360.580.831.150.52
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Analysts/Institutional Investor Meet/Con. Call Updates 
Announced OnFeb 1, 2023

Alembic Pharmaceuticals Limited has informed the Exchange about Link of Recording | Download

Alembic Pharmaceuticals Limited has informed the Exchange about Link of Recording | Download

Financial Result Updates 
Announced OnFeb 1, 2023

Alembic Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended December 31, 2022. | Download

Alembic Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended December 31, 2022. | Download

Cash Dividend 
Ex. DateAug 17, 2022

Interim • Div/Share: ₹ 10

See all events